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Abstract 
Synthetic hydrogels selectively decorated with cell adhesion motifs are rapidly emerging as promising 
substrates for 3D cell culture. When cells are grown in 3D they experience potentially more 
physiologically relevant cell-cell interactions and physical cues compared with traditional 2D cell 
culture on stiff surfaces. A newly developed polymer based on poly(2-oxazoline)s has been used for 
the first time to control attachment of fibroblast cells and is discussed here for its potential use in 3D 
cell culture with particular focus on cancer cells towards the ultimate aim of high throughput screening 
of anti-cancer therapies. Advantages and limitations of using poly(2-oxazoline) hydrogels are 
discussed and compared with more established polymers, especially polyethylene glycol (PEG). 
 
Introduction: 
In recent years, scientist have prospected great impact of three-dimensional (3D) cell culture, 
including a revolution in science and medicine enabled by accurate reproduction of healthy or 
diseased tissue in vitro.
1 
To realise this lofty and paradigm shifting goal an overhaul of cell culture 
technology is needed and, to do so, new materials must be developed to replace the ubiquitous flat 
tissue culture flask. The interest in 3D cell culture is not surprising given the dissimilarities between 
the stiff plastic used in the majority of culture vessels and the soft extracellular matrix in which cells 
naturally grow.
2
 Cancer researchers were amongst the first to adopt 3D soft matrices as the substrate 
of choice for culturing cancer cells where multi-cellular spheroids can mimic the organization 
observed in tumors
2
 These spheroids have proven extremely useful in researching anti-proliferative 
drugs and cancer cell biology and offer more relevant information compared with 2D cultures, which 
poorly predict the chemosensitivity of drugs. 
2 
 
 There are numerous strategies available for growing cells in 3D scaffolds based on natural or 
synthetic materials with forms ranging from rigid porous architectures to soft hydrogels. For hard 
tissue, such as bone, 3D printing of thermoplastics has proven successful,
3
 but for most other tissue 
types soft hydrogel scaffolds, that mimic the biomechanical properties of the ECM, are more 
appropriate and are the focus of this commentary. The most common methods for creating 3D 
hydrogels for culture of cancer cells involves collagen or a product called Matrigel™ (BD 
Biosciences). Collagen is gelled by taking an acidic solution of soluble collagen and neutralizing it; 
Matrigel is gelled by raising the temperature of a solution thereof from around 10 °C to 37 °C. The 
gelation process of collagen and Matrigel is slow enough to allow mixing in and encapsulating of cells 
at a pH and temperature close to physiological conditions. Matrigel is produced from mouse sarcomas 
and contains a cocktail of growth factors, sugars and undefined proteins, including enzymes. From a 
cellular perspective, Matrigel can thus be considered as being incredibly ‘information’ rich as it 
contains a complex mixture of cell-signalling and enzymatic molecules, which is advantageous in that 
the matrix can be remodelled like ECM and the cells receive cues similar to in vivo. However, the 
complex and ill-defined mixture of components in Matrigel, the batch-to-batch viability, and the lack 
of physical and chemical control, provide a strong need for other, more defined approaches. This is 
especially true if high-throughput screening (HTS) assays are required where variations in the 
substrate could easily overshadow any changes in cell behavior. 
The most appealing alternative strategy, that has been pioneered by Hubbell, Lutolf and 
Anseth, is based on a totally bio-inert synthetic polymer hydrogel substrate decorated with the 
appropriate signalling molecules providing complete control of the chemistry and mechanical 
properties.
4-6
 HTS 3D assays then become feasible as the first substrate will be identical to the last, 
irrespective of the batch, and at the same time giving the scientist control over the density and 
presentation of cell-signalling molecules (at least until the cells begin to produce their own). The 
natural choice of polymer in these pioneering studies was polyethylene glycol (PEG) – the historical 
‘gold standard’ in biologically inert, non-toxic polymers, although PEG is not without its limitations.7  
A class of polymers that is recently gaining increasing interest as alternatives to PEG are the 
poly(2-oxazoline)s (full name poly(2-alkyl-2-oxazoline)s, abbreviated PAOx*).
7,8
 PAOx were first 
reported in the 1960s, but have been largely overlooked for biomedical applications, especially when 
compared to the more popular, and abundantly available, PEG. When materials were first being 
selected for use as protein conjugates, PEG was chosen over PAOx as at the time it was more readily 
available in high purity and the process of “PEGylation” was born.9 Ever after the FDA approval of 
PEGylated therapeutics it has been the polymer of choice for other biomedical applications, including 
3D hydrogels scaffolds for cell culture. 
 
 
* A universal abbreviation has yet to be decided on and poly(2-oxazoline)s are currently being referred to as 
PAOx, POx, POXA, POz, and POZO while the older literature also uses the term poly(acyl ethylene imine)s. 
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 Unlike PEG, PAOx does not refer to just a single polymer structure but to a class of polymers 
with a common pseudo-polypeptide backbone and side chain ‘R’ group. This R group is most 
commonly a methyl or ethyl group as these polymers are readily soluble in water but it can also 
contain reactive functionalities in high fidelity. The ability to easily combine monomers with different 
R and end groups has lead to a diverse range of PAOx structures available (Figure 1) with properties 
ranging from super hydrophilic to amphiphilic, and from inert to reactive leading to a breadth of 
applications in protein conjugates, micelles, nanoparticles and hydrogels.
8
 This large synthetic 
versatility of PAOx with regard to polymer architecture, functionalities and physiochemical properties 
is in stark contrast to PEG that is limited to linear and star-shaped polymers bearing only chain-end 
functionalities. Furthermore, the side-chain is a highly important function of PAOx not found in PEG 
as it allows not just tuning of the physicochemical properties but also for the incorporation of higher 
number of bioactive moieties including cell-interacting peptides. 
 
 The excellent potential for PAOx as a biomaterial has recently been discussed in several 
review articles, and this is rapidly gaining attention.
10-12
 This increasing interest is reflected in the 
number of publications from 1966 to 2012 dealing with PAOx (Figure 2) showing a rapid growth in 
total number of PAOx publications and a blossoming interest in PAOx for the life sciences, especially 
in the last decade. Besides the synthetic versatility of PAOx as discussed above, the exceptional 
protein resistance and superior stability of PAOx compared with PEG are other key factors that 
explain the growing interest in PAOx.
13
 Similar to PEG, the protein resistance of PAOx originates 
from efficient hydration of the polymer chains giving them a ‘water-like’ structure that excludes 
protein interactions and gives the polymer ‘stealth’ properties to proteins and consequently cells. The 
resistance to other bio-molecules has been successfully exploited in DNA chips
14
 and carbohydrate 
microarrays
15
 where background noise due to non-specific binding would render the devices unusable. 
This combination of bio-stealth behavior and ability to be decorated with functional moieties makes 
PAOx an interesting candidate for 3D cell culture substrates. 
 
Poly(2-oxazoline) Hydrogels for Controlled Fibroblast Adhesion 
There are many reported strategies for making PAOx hydrogels, yet all of them employ 
conditions harmful to proteins and cells, such as toxic crosslinkers, organic solvents or high 
temperatures.
17
 Our first attempts of preparing PAOx hydrogels were based on a copolymer with ethyl 
and 9-decenyl side chains, which turned out to be insoluble in water, so hydrogels had to be prepared 
in ethanol followed by solvent exchange.
18
 Now, we have recently demonstrated a method to 
synthesize PAOx based hydrogels using mild aqueous curing conditions with the ability to include 
short peptides covalently bound to the polymer that overcomes this limitation.
19
 The approach uses a 
simple aqueous solution of precursor materials consisting of a water soluble PAOx copolymer with 
methyl, which is more water-soluble than the ethyl used previously) and 9-decenyl side chains 
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(pendant alkene groups), a dithiol crosslinker (in this study we used dithiothreitol), thiol-containing 
peptides (exploiting the thiol in the cysteine residue), and a low percentage of a radical photoinitiator. 
The solution is then exposed to low flux 365 nm light for several minutes to cure the polymer solution 
(schematic shown in Figure 3) into a highly transparent crosslinked hydrogel disc that exhibits low 
autofluorescence making it ideal for high contrast imaging and potential antibody based detection of 
biomarkers in fixed cells. In this published work, the peptides were first attached to the PAOx 
followed by crosslinking in a two-step procedure, but recent unpublished experiments have shown that 
the process works equally well as a one-pot process where the peptide incorporation and crosslinking 
occur simultaneously.  Fibroblast cells were seeded onto these hydrogel discs and were found to be 
completely non-adherent to the control PAOx hydrogels demonstrating their stealth behavior. When 
cells were seeded on hydrogel discs containing the well-known cell binding RGD peptide motif 
common to fibronectin, laminin and collagen, the cells attached and proliferated covering the entire 
top surface of the hydrogels. This is certainly not the first time that cell integrin binding peptide 
sequences have been incorporated into hydrogels and cells grown on top, but it was the first instance 
of it being done with a PAOx hydrogel, thereby providing the first proof-of-principle of PAOx 
hydrogel scaffolds for cell culture. For further proof of principle we encapsulated the fibroblasts 
within the hydrogel matrix to demonstrate the possibility of preparing 3D culture. To do this, the cells 
were mixed with the hydrogel precursor solution and irradiated with light to initiate the curing 
process. A live/dead assay showed that the cells were largely unaffected by the curing process and 
were viable within the 3D hydrogel. 
The use of light to cure hydrogels has many advantages and indeed it is a commonly 
employed technique in dentistry as well as for making cell-encapsulated scaffolds for tissue 
engineering. The thiol-ene reaction used to cure the PAOx hydrogels involves abstraction of a proton 
from the thiol which subsequently reacts with a carbon-carbon double bond.
20
 The reaction can be 
used under aqueous conditions, is relatively insensitive to oxygen, except in some instances,
21
 and 
works well with the thiol of cysteine meaning that almost any peptide can be incorporated as long as it 
contains a non-oxidized cysteine residue. The curing reaction can be ‘switched-on’ at will and proceed 
with predictable kinetics
18
 using the light source, which is a distinct advantage over ECM protein 
hydrogels where the gelation process is difficult to control and adds pressure on the user, especially 
when trying to simultaneously handle cells in multiple parallel experiments. Light curing also opens 
up possibilities of creating specific hydrogels patterns and gradients in 2D using photomasks
22
 or even 
in 3D using 2-photon initiation methods
23
 and 3D printers.
24
 The latter of these, using printers to make 
3D shapes from hydrogels is an area of great interest as cells can be incorporated during the printing 
process and is a method that could be compatible with PAOx via extrusion of the soluble polymer 
followed by light curing. The use of light, however, is not without risk, especially when used in the 
presence of cells. This is often overlooked by tissue engineers who use UV light to encapsulate cells in 
polymer matrices with the goal to create as much new ECM as possible and some collateral cell 
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damage may not be harmful. For cancer research in 3D, however, the possible DNA dimerization as a 
result of UV exposure would need to be monitored carefully to ensure that any changes in cell 
behavior are not due to the curing conditions themselves. We used extremely low power UV 
irradiation in our study, but, nevertheless, caution is required to avoid unwanted effects on the cells. 
Strategies to overcome this potential limitation include seeding the cells on top of the post-cured 
hydrogel and have them migrate in, or to use different curing chemistry. Fortunately, the versatility of 
PAOx means developing the new chemistry needed is within reach. 
Future application of PAOx hydrogels – Cancer research 
As mentioned, we have recently reported the successful attachment and proliferation of 
fibroblast cells seeded onto RGD functionalized PAOx hydrogels.
19
 To assess the utility of PAOx 
hydrogels for cancer research applications we have extended these results to include both normal 
(MCF-10A; Figure 4; data not published earlier) and malignant (MCF-7, MDA-MB-231; unpublished 
data not shown) breast epithelial cell lines. The hydrogels and conditions were the same as those used 
for the experiments with fibroblasts as previously reported.
19
  As shown in Figure 4, the highly 
adherent MCF-10A cell line failed to attach to non-functionalized PAOx hydrogels (left panel) further 
confirming the protein resistance of the base polymer hydrogel. In contrast, RGD-functionalized 
hydrogels provided an excellent substrate for cell attachment supporting the proliferation of cells over 
14 days (middle and right panels). Importantly, cells grown on RGD-functionalized PAOx hydrogels 
grew as epithelial colonies with characteristic cortical F-actin organization (Figure 4, middle and right 
panels), thus maintaining their epithelial phenotype during culture. In addition to monitoring cell 
attachment, motility and proliferation in 2D, the versatile nature of PAOx hydrogels will allow for the 
straight-forward inclusion of protease degradable crosslinks. This will open the door to studies of 
cellular invasion processes as cells secreting specific proteases would degrade the crosslinks, invade 
and migrate downwards into the PAOx hydrogel forming a 3D invasion model. This may also 
circumvent the need to encapsulate cells within the hydrogel to study cell invasion. Whether tumor 
cells are seeded directly on top or encapsulated within hydrogels, PAOx has great potential as an ideal 
cellular support for 3D studies of cancer cell behavior.  
Outlook 
 The relatively recent recognition of the fact that studies performed in 3D scaffolds more 
accurately recapitulate the complex cell-cell and cell-matrix interactions occurring in vivo than 2D cell 
culture, has led to a rapid increase in the number and types of both natural and synthetically derived 
matrices for 3D culture models.
25
 Cancer researchers have been quick to adopt these 3D models into 
their pre-clinical repertoire to provide more physiologically relevant conditions for the study of tumor 
cell biology. These 3D models hold the potential to enable more accurate insights into the response of 
tumor cells to chemotherapeutic agents, discovery of clinically relevant biomarkers and for identifying 
molecular and cellular mechanisms underpinning disease progression and metastasis. With the rapidly 
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increasing use of high-throughput functional genomic and drug screening technologies, appropriate, 
defined and reproducible 3D models are becoming increasingly important for inclusion into these 
assays to generate more reliable and physiologically relevant “hits” or candidates for further 
development. Whether 3D models are used in the primary screening assay or for secondary validation 
studies, the incorporation of these models into HTS studies will undoubtedly increase, and along with 
it, more robust therapeutic targets will be identified. The potential of PAOx to be functionalized or 
encapsulated with biological peptides and growth factors, siRNA molecules and therapeutic 
compounds, at least conceptually, may pave the way for more sophisticated 3D cell culture systems to 
assess cancer cell biology.     
Undoubtedly a number of technical challenges remain before 3D models are routinely used in 
robust HTS systems,
26,27
 but the versatility of synthetic polymers such as PAOx may help to accelerate 
their use in these systems. More likely than not, any successful approach using PAOx (or any other 
synthetic polymer) will not just involve the pure functionalized synthetic polymer, but rather hybrid 
scaffolds of PAOx in combination with recombinant protein-based scaffolds. This makes it a 
potentially cost-effective approach to prepare 3D structures, which could be conceived to contain 
spatial segmentation of signalling molecules including morphogens or patterning of structural features 
to allow for tissue-like hierarchical cellular organization, including vascular channels. High quality 
PAOx can be synthesized in gram to kilogram quantities relatively cheaply and the chemistry is 
constantly being improved, including extension of the number of functional groups that can be 
incorporated. The commercial availability of new PAOx polymers is ever increasing and companies 
such as Serina Therapeutics
28
 (drug delivery) and GATT Technologies
29
 (tissue sealants) are paving 
the way for the inevitable wide-spread use of this highly potent class of polymers.  
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Figures  
 
Figure 1: General structure of poly(2-oxazoline)s (top left) and a selection of easily accessible 
functional PAOx structures ranging from linear with variable chain end or side chain functionalities to 
stars highlighting the structural versatility of this class of polymers.  
 
Figure 2: The popularity of PAOx highlighted by the cumulative number of publications in all fields 
(top line) and in biology and biomaterials (bottom line) from 1966 to 2012. Source: SciFinder
16
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Figure 3: Synthesis of functional PAOx hydrogels. Schematic showing the modular approach of 
attaching peptides to the polymer side-chains and crosslinking. 
 
 
 
Figure 4: Confocal microscopy images of MCF-10A cells seeded onto PAOx hydrogels with no RGD 
(left panel) and functionalized with RGD (middle and right panel). Cells were grown in regular growth 
media for 14 days before being stained with phalloidin and DAPI. Scale bars shown. 
